Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, according to a new report in the Journal of Allergy and Clinical Immunology.
Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, according to a new report in the Journal of Allergy and Clinical Immunology.